Pomerantz LLP is investigating claims of securities fraud against Nutex Health Inc. (NASDAQ: NUTX) on behalf of investors. The investigation concerns allegations that Nutex and its officers and directors may have engaged in unlawful business practices. The stock price fell 10.05% after a Blue Orca report alleged that Nutex faces litigation risk due to its relationship with HaloMD, a third-party vendor sued for a "coordinated fraudulent scheme."
Pomerantz LLP, a renowned law firm specializing in corporate and securities litigation, has initiated an investigation into allegations of securities fraud against Nutex Health Inc. (NASDAQ: NUTX) on behalf of its investors. The investigation focuses on whether Nutex and its officers and directors engaged in unlawful business practices [3].
The investigation was triggered by a report published by Blue Orca Capital on July 22, 2025. The report alleged that Nutex faces litigation risk due to its relationship with HaloMD, a third-party vendor that was recently sued for a "coordinated fraudulent scheme" to take millions from insurance companies on behalf of healthcare billing clients [2]. Following the publication of the report, Nutex's stock price fell by 10.05%, closing at $100.01 per share [2].
Pomerantz LLP encourages investors who have suffered losses to contact Danielle Peyton at 646-581-9980, ext. 7980, to discuss their rights. The firm has a proven track record of recovering multimillion-dollar damages for class members in securities fraud cases [3].
References:
[1] https://www.marketscreener.com/news/nutx-investors-have-opportunity-to-join-nutex-health-inc-fraud-investigation-with-the-schall-law-fi-ce7c51ded181f521
[2] https://www.globenewswire.com/news-release/2025/08/12/3132033/32716/en/Nutex-Health-NUTX-Shares-Fall-Amid-Critical-Blue-Orca-Report-Hagens-Berman.html
[3] https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-nutex-health-inc---nutx-302527399.html
Comments
No comments yet